
Join to View Full Profile
Seattle Cancer Care AllianceSeattle, WA 98109
Phone+1 206-606-7222
Dr. King is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of ColoradoFellowship, Hematology and Medical Oncology, 2018
- Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2014
- University of Santo TomasClass of 2007
Certifications & Licensure
- WA State Medical License 2019 - 2025
- CO State Medical License 2018 - 2021
- PA State Medical License 2010 - 2016
Clinical Trials
- Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer Start of enrollment: 2020 Jul 08
Publications & Presentations
PubMed
- Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.Lakshmi Rajdev, Gentry G King, Christopher H Lieu, Stacey A Cohen, Shubham Pant
JCO Precision Oncology. 2025-03-01 - 1 citationsSWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Canc...Rachna T Shroff, Gentry King, Sarah Colby, Aaron J Scott, Mitesh J Borad
Journal of Clinical Oncology. 2025-02-10 - 10 citationsFutibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors.Milind Javle, Gentry King, Kristen Spencer, Mitesh J Borad
The Oncologist. 2023-11-02
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: